Abigail Fahim, MD
Ophthalmology · Ann Arbor, MINPI 1669768198
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,728 of the $13,825 with a category attached, or 99.3%. 4 manufacturers reported payments, led by Actelion Pharmaceuticals US, Inc. at 37.5% of the total. Reporting peaked in 2023 at $5,180 and has fallen 76.5% since, to $1,219 in 2025. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $987.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$5K
- Johnson & Johnson$5K
- Janssen Research & Development, LLC$4K
- AbbVie$97
Across 12 payments — averaging $6806.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$82K
- AbbVie$11
What the payments were for
- Consulting fees$13,72899%
- Food & beverage$971%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $5,180 |
| Johnson & Johnson | 11 | $4,798 |
| Janssen Research & Development, LLC | 1 | $3,750 |
| AbbVie | 1 | $97 |
How this compares
$13,825 in reported general payments places this provider in the 90th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $289 |
| Latanoprost | 15 | $111 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Ann Arbor
- Manjool ShahAnn Arbor$609K
- David ZacksAnn Arbor$177K
- Jason MillerAnn Arbor$104K
- Yannis PaulusAnn Arbor$85K
- Shilpa KodatiAnn Arbor$75K
- Amanda BicketAnn Arbor$34K
- Vinay AakaluAnn Arbor$16K
- Nita ValikodathAnn Arbor$16K
- Marguerite WeinertAnn Arbor$16K
- Shahzad MianAnn Arbor$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.